LEOCLAN Co.,Ltd. (TYO:7681)
Japan · Delayed Price · Currency is JPY 932.00
-20.00 (-2.10%)
Feb 17, 2026, 9:01 AM JST
LEOCLAN Market Cap
LEOCLAN has a market cap or net worth of 5.52 billion as of February 13, 2026. Its market cap has decreased by -6.51% in one year.
Market Cap
5.52B
Enterprise Value
4.05B
Revenue
28.69B
Ranking
n/a
PE Ratio
23.26
Stock Price
932.00
Market Cap Chart
Since October 2, 2019, LEOCLAN's market cap has decreased from 6.65B to 5.52B, a decrease of -17.03%. That is a compound annual growth rate of -2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 16, 2026 | 5.52B | -9.25% |
| Dec 30, 2025 | 6.08B | 9.37% |
| Dec 30, 2024 | 5.56B | 2.61% |
| Dec 29, 2023 | 5.42B | 0.58% |
| Dec 30, 2022 | 5.39B | -0.36% |
| Dec 30, 2021 | 5.41B | 22.82% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 15.27T |
| HOYA Corporation | 9.51T |
| Takeda Pharmaceutical Company | 8.87T |
| Otsuka Holdings | 5.59T |
| Sapporo Clinical Laboratory | 6.09B |
| Care Twentyone | 5.98B |
| Shigematsu Works | 5.95B |
| Carna Biosciences | 5.89B |